Comparison of Daily Dose of 400 and 600 Units of Vitamin D in the Prevention of Osteopenia of Prematurity in Infants with a Gestational Age of Less Than and Equal to 32 Weeks.

IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL
International Journal of Preventive Medicine Pub Date : 2024-10-18 eCollection Date: 2024-01-01 DOI:10.4103/ijpvm.ijpvm_236_23
Behzad Barekatain, Shima Hamidipour, Zohreh Badiei, Maryam Farghadani
{"title":"Comparison of Daily Dose of 400 and 600 Units of Vitamin D in the Prevention of Osteopenia of Prematurity in Infants with a Gestational Age of Less Than and Equal to 32 Weeks.","authors":"Behzad Barekatain, Shima Hamidipour, Zohreh Badiei, Maryam Farghadani","doi":"10.4103/ijpvm.ijpvm_236_23","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The use of vitamin D in premature infants is one of the important preventive factors for osteopenia of prematurity, but there are conflicting results on the appropriate doses, so this study aimed to compare the doses of 400 and 600 units of vitamin D in the prevention of osteopenia of prematurity in infants with a gestational age ≤32 weeks.</p><p><strong>Methods: </strong>This clinical trial study was conducted on 108 premature infants divided into two groups of 54 with a gestational age of ≤32 weeks born between 2020 and 2021 in Shahid Beheshti and Al-Zahrai hospitals in Isfahan. In the first group, daily vitamin D was 400 units from the 7<sup>th</sup> day of birth, and in the second group, it was 600 units. At the age of 5 weeks, levels of calcium, phosphorus, alkaline phosphatase (ALP), and vitamin D were evaluated. If the ALP level was above 1000, wrist radiography was requested. Also, the baby was examined for clinical symptoms of rickets at the age of 5 weeks. The data were analyzed by Statistical Package for the Social Sciences (SPSS) software version 26, and a P value <0.05 was considered significant.</p><p><strong>Results: </strong>In this study, there was no significant difference between the levels of ALP in the two groups (<i>P</i> = 0.596), but the level of vitamin D was significantly higher in the 600 units of vitamin D group (<i>P</i> < 0.001). The level of calcium was higher in the 400 units of vitamin D group, but this difference was slightly significant (<i>P</i> = 0.062). The level of phosphorus in the 600 units of vitamin D group was higher than in the 400 units of vitamin D group, and the difference was slightly significant (<i>P</i> = 0.062).</p><p><strong>Conclusions: </strong>This study showed that daily doses of 600 and 400 units of vitamin D in infants with a gestational age of ≤32 weeks had no effect on the incidence of clinical symptoms and radiological findings of rickets at the age of 5 weeks.</p>","PeriodicalId":14342,"journal":{"name":"International Journal of Preventive Medicine","volume":"15 ","pages":"55"},"PeriodicalIF":1.7000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559709/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Preventive Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijpvm.ijpvm_236_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The use of vitamin D in premature infants is one of the important preventive factors for osteopenia of prematurity, but there are conflicting results on the appropriate doses, so this study aimed to compare the doses of 400 and 600 units of vitamin D in the prevention of osteopenia of prematurity in infants with a gestational age ≤32 weeks.

Methods: This clinical trial study was conducted on 108 premature infants divided into two groups of 54 with a gestational age of ≤32 weeks born between 2020 and 2021 in Shahid Beheshti and Al-Zahrai hospitals in Isfahan. In the first group, daily vitamin D was 400 units from the 7th day of birth, and in the second group, it was 600 units. At the age of 5 weeks, levels of calcium, phosphorus, alkaline phosphatase (ALP), and vitamin D were evaluated. If the ALP level was above 1000, wrist radiography was requested. Also, the baby was examined for clinical symptoms of rickets at the age of 5 weeks. The data were analyzed by Statistical Package for the Social Sciences (SPSS) software version 26, and a P value <0.05 was considered significant.

Results: In this study, there was no significant difference between the levels of ALP in the two groups (P = 0.596), but the level of vitamin D was significantly higher in the 600 units of vitamin D group (P < 0.001). The level of calcium was higher in the 400 units of vitamin D group, but this difference was slightly significant (P = 0.062). The level of phosphorus in the 600 units of vitamin D group was higher than in the 400 units of vitamin D group, and the difference was slightly significant (P = 0.062).

Conclusions: This study showed that daily doses of 600 and 400 units of vitamin D in infants with a gestational age of ≤32 weeks had no effect on the incidence of clinical symptoms and radiological findings of rickets at the age of 5 weeks.

在预防胎龄小于或等于 32 周的早产儿骨质疏松症方面,每天服用 400 单位和 600 单位维生素 D 的比较。
背景:早产儿服用维生素D是预防早产儿骨质疏松症的重要因素之一,但关于适当剂量的结果却相互矛盾,因此本研究旨在比较400和600单位的维生素D剂量在预防胎龄小于32周的早产儿骨质疏松症方面的效果:这项临床试验研究的对象是伊斯法罕 Shahid Beheshti 医院和 Al-Zahrai 医院的 108 名早产儿,分为两组,每组 54 名,胎龄≤32 周。第一组婴儿从出生后第 7 天起每天摄入 400 单位的维生素 D,第二组婴儿每天摄入 600 单位的维生素 D。5 周大时,对钙、磷、碱性磷酸酶(ALP)和维生素 D 的水平进行评估。如果 ALP 水平超过 1000,则需要进行腕部 X 射线检查。此外,还检查了婴儿 5 周大时是否出现佝偻病的临床症状。数据采用社会科学统计软件包(SPSS)第 26 版进行分析,P 值为 结果:在本研究中,两组的 ALP 水平无明显差异(P = 0.596),但 600 单位维生素 D 组的维生素 D 水平明显更高(P < 0.001)。400 单位维生素 D 组的钙含量更高,但差异略微显著(P = 0.062)。维生素 D 600 单位组的磷含量高于维生素 D 400 单位组,差异略有显著性(P = 0.062):这项研究表明,胎龄≤32周的婴儿每天服用600和400单位的维生素D对5周大时佝偻病的临床症状和放射学检查结果的发生率没有影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Preventive Medicine
International Journal of Preventive Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
3.20
自引率
4.80%
发文量
107
期刊介绍: International Journal of Preventive Medicine, a publication of Isfahan University of Medical Sciences, is a peer-reviewed online journal with Continuous print on demand compilation of issues published. The journal’s full text is available online at http://www.ijpvmjournal.net. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. The journal will cover technical and clinical studies related to health, ethical and social issues in field of Preventive Medicine. Articles with clinical interest and implications will be given preference.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信